Nextracker Inc. NXT 深 沪
已收盘 11-14 16:00:00 美东时间
93.75
+5.660
+6.43%
华盛通- 最 高95.465
- 今 开84.27
- 成交量 362.54万股
- 最 低 83.06
- 昨 收 88.09
- 总市值 138.75亿
- 52周最高 112.74
- 市盈率 静 27.06
- 换手率 2.45%
- 52周最低 33.29
- 委 比 -7.33%
- 总股本 1.48亿
- 历史最高 112.74
- 量 比 1.27
- 振 幅 14.08%
- 历史最低 28.2401
- 每 手 1
- 风险率 17.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
Roth Capital Reiterates Buy on Nextracker, Maintains $120 Price Target
Roth Capital analyst Philip Shen reiterates Nextracker (NASDAQ:NXT) with a Buy and maintains $120 price target.
11-14 00:26
10 Industrials Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
11-13 01:35
Nextpower Reaffirms FY26 Outlook, Targets $4.8B-$5.6B Revenue By FY30, With Approximately One-Third Of Revenue Expected To Come From Sales Of Non-Tracker Products And Services
In conjunction with the company's Capital Markets Day being held today, Nextpower reaffirms its FY26 outlook and announces its FY27 outlook and long-term financial targets, including $4.8 billion to $5.6 billion in
11-12 22:18
NEXTracker Rebrands to Nextpower, Expands Energy Solutions
NEXTracker, Inc. Class A ( ($NXT) ) has issued an announcement. On November 12,...
11-12 21:59
Peering Into Nextracker Inc's Recent Short Interest
Nextracker Inc's (NYSE:NXT) short interest as a percent of float has fallen 13....
11-11 01:00
Jim Cramer Says Stay Away From AT&T, Calls Nextracker 'Tremendous'
AT&T reported third-quarter operating revenues of $30.71 billion. It fell short of the analyst consensus estimate of $30.87 billion.
11-03 20:59
Small Cap Stock Rockets: Top 10 IWM Holdings' Eye-Popping Rally
All of the IWM's top ten holdings are up by triple digits over the past six months.
10-31 02:12
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
10-30 14:22
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
